Accueil/Actions/MCRB

MCRB

USD

Seres Therapeutics Inc. Common Stock

$13.750-1.380 (-9.121%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$15.130

Haut

$15.340

Bas

$13.750

Volume

0.08M

Fondamentaux de l'Entreprise

Capitalisation Boursière

120.4M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.16M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $6.53Actuel $13.750Haut $24.665

Actualités Connexes

29 oct. 2025 · 11:00

GlobeNewswire

Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155

CAMBRIDGE, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), a leading live biotherapeutics company, today announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical

Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155

14 oct. 2025 · 11:00

GlobeNewswire

Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant

CAMBRIDGE, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), (Seres or the Company), a leading live biotherapeutics company, today announced that new post hoc data from its SER-155 Phase